1,968
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen

, , , &
Pages s90-s92 | Published online: 12 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Heng Sheng Sow & Stephen R Mattarollo. (2013) Combining low-dose or metronomic chemotherapy with anticancer vaccines. OncoImmunology 2:12.
Read now

Articles from other publishers (13)

Vibor Milunović, Ida Hude, Goran Rinčić, Davor Galušić, Aron Grubešić, Marko Martinović, Nika Popović, Sunčana Divošević, Klara Brčić, Marin Međugorac, Luka Kužat, Dejan Strahija, Stefan Mrđenović, Inga Mandac Smoljanović, Delfa Radić-Krišto, Slavko Gašparov, Igor Aurer & Slobodanka Ostojić Kolonić. (2022) Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review. Biomedicines 10:11, pages 2917.
Crossref
Maria Christina Cox & Guido Bocci. (2022) Metronomic chemotherapy regimens and targeted therapies in non-Hodgkin lymphoma: The best of two worlds. Cancer Letters 524, pages 144-150.
Crossref
Katrin Schmittlutz & Reinhard Marks. (2021) Current treatment options for aggressive non-Hodgkin lymphoma in elderly and frail patients: practical considerations for the hematologist. Therapeutic Advances in Hematology 12, pages 204062072199648.
Crossref
Osnat Bairey & Tali Siegal. (2018) The possible role of maintenance treatment for primary central nervous system lymphoma. Blood Reviews 32:5, pages 378-386.
Crossref
C. Buske, M. Hutchings, M. Ladetto, V. Goede, U. Mey, P. Soubeyran, M. Spina, R. Stauder, M. Trněný, U. Wedding, P. Fields, Christian Buske, Martin Dreyling, Andrés J M Ferreri, Paul Fields, Gianluca Gaidano, Valentin Goede, Martin Hutchings, Marco Ladetto, Steven Le Gouill, Stefano Luminari, Ulrich Mey, Peter de Nully Brown, Michael Pfreundschuh, Christiane Pott, Norbert Schmitz, Pierre Soubeyran, Michele Spina, Reinhard Stauder, Anna Sureda Balari, Marek Trněný, Gustaaf van Imhoff, Jan Walewski, Ulrich Wedding, Alberto Zamò & Emanuele Zucca. (2018) ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma. Annals of Oncology 29:3, pages 544-562.
Crossref
Pierre Soubeyran & Rémy Gressin. (2016) Treatment of the elderly patient with mantle cell lymphoma. Hematology 2016:1, pages 425-431.
Crossref
Herman A Perroud, Carlos M Alasino, Maria J Rico, Francisco Queralt, Stella M Pezzotto, Viviana R Rozados & O Graciela Scharovsky. (2016) Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy. Future Oncology 12:10, pages 1233-1242.
Crossref
D. López Aventín, F. Gallardo, B. Sanchez‐Gonzalez, R.M. Pujol & A. Salar. (2014) Metronomic chemotherapy for advanced and refractory cutaneous T‐cell lymphoma treatment. Journal of the European Academy of Dermatology and Venereology 30:1, pages 136-138.
Crossref
Anna Dmoszyńska, Elżbieta Starosławska & Krzysztof Giannopoulos. (2015) Terapia metronomiczna w hematoonkologii: nadzieje i fakty. Acta Haematologica Polonica 46:5, pages 353-358.
Crossref
Simone Ferrero & Martin Dreyling. 2015. Management of Hematological Cancer in Older People. Management of Hematological Cancer in Older People 143 168 .
M Dreyling, S Ferrero & O Hermine. (2014) How to manage mantle cell lymphoma. Leukemia 28:11, pages 2117-2130.
Crossref
Nicolas André, Manon Carré & Eddy Pasquier. (2014) Metronomics: towards personalized chemotherapy?. Nature Reviews Clinical Oncology 11:7, pages 413-431.
Crossref
Rena Buckstein, Robert Kerbel, Matthew Cheung, Yuval Shaked, Lisa Chodirker, Christina R. Lee, Martha Lenis, Cindy Davidson, Mary-Anne Cussen, Marciano Reis, Alden Chesney, Liying Zhang, Alexandre Mamedov & Richard A. Wells. (2014) Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis. Leukemia Research 38:7, pages 756-763.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.